Introduction: fusidic acid enters the United States.
Publication
, Journal Article
Moellering, RC; Corey, GR; Grayson, ML
Published in: Clin Infect Dis
June 2011
Duke Scholars
Published In
Clin Infect Dis
DOI
EISSN
1537-6591
Publication Date
June 2011
Volume
52 Suppl 7
Start / End Page
S467 / S468
Location
United States
Related Subject Headings
- United States
- Staphylococcal Infections
- Skin Diseases, Bacterial
- Microbiology
- Methicillin-Resistant Staphylococcus aureus
- Humans
- Gram-Positive Cocci
- Fusidic Acid
- Drug Approval
- Clinical Trials as Topic
Citation
APA
Chicago
ICMJE
MLA
NLM
Moellering, R. C., Corey, G. R., & Grayson, M. L. (2011). Introduction: fusidic acid enters the United States. Clin Infect Dis, 52 Suppl 7, S467–S468. https://doi.org/10.1093/cid/cir171
Moellering, Robert C., G Ralph Corey, and M Lindsay Grayson. “Introduction: fusidic acid enters the United States.” Clin Infect Dis 52 Suppl 7 (June 2011): S467–68. https://doi.org/10.1093/cid/cir171.
Moellering RC, Corey GR, Grayson ML. Introduction: fusidic acid enters the United States. Clin Infect Dis. 2011 Jun;52 Suppl 7:S467–8.
Moellering, Robert C., et al. “Introduction: fusidic acid enters the United States.” Clin Infect Dis, vol. 52 Suppl 7, June 2011, pp. S467–68. Pubmed, doi:10.1093/cid/cir171.
Moellering RC, Corey GR, Grayson ML. Introduction: fusidic acid enters the United States. Clin Infect Dis. 2011 Jun;52 Suppl 7:S467–S468.
Published In
Clin Infect Dis
DOI
EISSN
1537-6591
Publication Date
June 2011
Volume
52 Suppl 7
Start / End Page
S467 / S468
Location
United States
Related Subject Headings
- United States
- Staphylococcal Infections
- Skin Diseases, Bacterial
- Microbiology
- Methicillin-Resistant Staphylococcus aureus
- Humans
- Gram-Positive Cocci
- Fusidic Acid
- Drug Approval
- Clinical Trials as Topic